Back

American Society of Cytopathology

  • Lymphadenopathy
  • Lymphoma

Innovative Approaches in Lymphoma Diagnosis: Small Specimens, Big Impact

This presentation addresses critical gaps in the use of FNA for evaluating lymphadenopathy, emphasizing its potential as a minimally invasive, cost-effective diagnostic tool with the ability to quickly triage patients. Despite its many advantages, diagnosing lymphoma through FNA presents challenges, particularly with paucicellular samples and the need for high-quality specimens and ancillary testing for accurate categorization using recent classification systems. The importance of a multidisciplinary approach and collaboration between cytopathologists and hematopathologists, for enhanced diagnostic accuracy and optimal patient care is emphasized. The goal of the presentation is to empower participants to be able to categorize patients into diagnostic groups with specific risks of malignancy that guide further management decisions rather than striving for definitive WHO/ICC diagnoses.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AMA PRA Category 1 Credit™Up to 2 credits

MOC types

ABPATH — Lifelong LearningUp to 2 points

FDA REMS

No

Qualifies for MIPS

No

Target Specialties

Pricing

$105

Standard

Listed by the provider · education.cytopathology.org

  • Case-based learning
  • includes Board review / self-assessment
  • Credit · Up to 2 credits
  • MOC · Up to 2 points
  • $105
  • Released
    Feb 24, 2026
  • Last day to claim credit
    Feb 24, 2029 2 years left